Skip to main content
Medicine LibreTexts

3.4: Syringe and Needle Selection

  • Page ID
    19728
    \( \newcommand{\vecs}[1]{\overset { \scriptstyle \rightharpoonup} {\mathbf{#1}} } \) \( \newcommand{\vecd}[1]{\overset{-\!-\!\rightharpoonup}{\vphantom{a}\smash {#1}}} \)\(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\) \(\newcommand{\id}{\mathrm{id}}\) \( \newcommand{\Span}{\mathrm{span}}\) \( \newcommand{\kernel}{\mathrm{null}\,}\) \( \newcommand{\range}{\mathrm{range}\,}\) \( \newcommand{\RealPart}{\mathrm{Re}}\) \( \newcommand{\ImaginaryPart}{\mathrm{Im}}\) \( \newcommand{\Argument}{\mathrm{Arg}}\) \( \newcommand{\norm}[1]{\| #1 \|}\) \( \newcommand{\inner}[2]{\langle #1, #2 \rangle}\) \( \newcommand{\Span}{\mathrm{span}}\)\(\newcommand{\AA}{\unicode[.8,0]{x212B}}\)

    Depending on the vaccine dose, health professionals should use a 1 mL or 3 mL syringe. Depending on the site of administration, it is important to select the right needle size to optimize the immune response and reduce the risk of injection site reactions. For example, vaccines with adjuvants need to be injected into the muscle and not the subcutaneous tissue to prevent inflammation and formation of granulomas. Furthermore, vaccine absorption can be impaired if the vaccine is inadvertently injected into lymphatic circulation. When selecting a needle length for an intramuscular (IM) injection, consider a length that is long enough to reach deep tissue without involving underlying bone, nerves, or blood vessels. Longer needles often result in less redness and swelling when compared to shorter needles. The selection of the right needle should be determined by: 1) route of administration; 2) the client’s age and size of muscle mass; 3) viscosity of the vaccine or passive immunizing agent. Table 3.3 offers needle selection guidelines to inform clinical judgement, which are then visualized in Images 3.2 and 3.3. It is important to note that the needle size recommendations are based on the practice of having the skin stretched flat between thumb and forefinger at the time of administration.

     

    Table 3.3: Needle Selection Guidelines

    Route of Administration Needle Gauge Age of vaccine recipient Site of injection Needle Length

    Intradermal (ID)

     

    26-27

     

    All ages

     

     

    1.0 cm

     

    Subcutaneous (SC)

    45 degree angle

     

    25

     

    All ages

     

    < 1 year: anterolateral thigh

    ≥ 1 year: upper triceps area or anterolateral thigh

     

    1.6 cm

     

    Intramuscular (IM)

    90 degree angle

     

    22-25

     

    Newborn (>28 days) and preterm infants

     

    Anterolateral thigh

     

    1.6 cm

     

    Infants (1 – 12 months)

     

    Anterolateral thigh

     

    2.2 – 2.5 cm

     

    Young children (>12 months – 3 years)

     

    Deltoid muscle

     

    1.6 – 2.5 cm

     

    Anterolateral thigh

     

    2.5 – 3.5 cm

     

    Children (>3 – 12 years)

     

    Deltoid muscle

     

    1.6 – 2.5 cm

     

    Anterolateral thigh

     

    2.5 – 3.5 cm

     

    Adolescents (>12 years – 18 years)

     

     

    Deltoid muscle

     

    Consult weight-based recommendations

     

    Anterolateral thigh

     

    2.5 – 3.2 cm

     

    Deltoid muscle

     

    For those weighing <130 lbs (<60 kg):

    1.6 cm – 2.5 cm (⅝ inch – 1 inch)

     

    Males weighing 130 – 260 lbs (60 – 118 kg)

    and females weighing 130 – 200 lbs (60 – 90 kg):

    2.5 cm (1 inch)

     

    Males weighing >260 lbs (118 kg) and females weighing >200 lbs (90 kg):

    3.8 cm (1½ inch)

     

     

    Subcutaneous-Injection-e1583168614192.jpeg
    Image 3.2: Subcutaneous injection
    Intramuscular-Injection-e1583168740188.jpeg
    Image 3.3: Intramuscular injection

    Points of Consideration

    Despite popular belief, there is no evidence to support avoiding injection through a tattoo or superficial birthmark.

     

    An interactive or media element has been excluded from this version of the text. You can view it online here:
    https://ecampusontario.pressbooks.pub/immunizations/?p=117


    Content in the Table 3.3 was adapted, with editorial changes, from: Page 8: Canadian Immunization Guide: Part 1 – Key Immunization Information by the Government of Canada and is reproduced under non-commercial conditions.


    This page titled 3.4: Syringe and Needle Selection is shared under a CC BY-SA 4.0 license and was authored, remixed, and/or curated by Oona St-Amant, Jennifer Lapum, Vinita Dubey, Karen Beckermann, Che-Sheu Huang, Carly Weeks, Kate Leslie, and Kim English (eCampus Ontario) via source content that was edited to the style and standards of the LibreTexts platform; a detailed edit history is available upon request.